Insider Insights
28.07.2022
Federal cabinet approves Lauterbachs draft GKV

One notable change from the last released updated bill was the removal of the solidarity levy of 2 b...

Read more
News
14.07.2022
PMA Insights: Week 28

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
13.07.2022
Big pharmas lose out in Chinas latest round of dru

AZ has warned its China revenues will decline mid-single-digit percentage in 2022 after years of dou...

Read more
Insider Insights
11.07.2022
New pharmaceutical updated cost containment measur

This updated bill contains some similar measures to those proposed in March as well as some addition...

Read more
Insider Insights
23.06.2022
AIFA reorganisation delayed again

It is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...

Read more
Insider Insights
21.06.2022
Sweden TLV considers cost containment measures

According to the TLV, “The prices of medicines that have been on the market between 5 and 15 years...

Read more
Insider Insights
20.06.2022
NICE trials new proportionate approach to increase

The aim of this trial is to increase capacity, with a goal of a 20% increase by 2023-24.

Read more
News
15.06.2022
PMA Insights: Week 24

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
15.06.2022
NHS announces further details of subscription styl

The subscription-style payment model for antibiotics announced by NICE in April 2022 will be capped ...

Read more
Insider Insights
25.05.2022
Access consortium recommended by NICE in draft gui

The Access Consortium is made up of regulatory authorities including the UK, Australia, Canada, Sing...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.